Wetherby Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

Wetherby Asset Management Inc

$2.08 Billion
Q2 2024

A detailed history of Wetherby Asset Management Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Wetherby Asset Management Inc holds 40,791 shares of TAK stock, worth $579,640. This represents 0.03% of its overall portfolio holdings.

Number of Shares

40,791

Previous 82,998 50.85%

Holding current value

$579,640

Previous $1.15 Million 54.25%

% of portfolio

0.03%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $531,808 - $576,969	-42,207 Reduced 50.85%	40,791 $527,000
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $52,573 - $56,926	-3,785 Reduced 4.36%	82,998 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $190,179 - $219,646	-14,235 Reduced 14.09%	86,783 $1.24 Million
Q3 2023 Nov 14, 2023	SELL	$15.03 - $16.32 $93,201 - $101,200	-6,201 Reduced 5.78%	101,018 $1.56 Million
Q2 2023 Aug 14, 2023	SELL	$15.57 - $17.11 $81,337 - $89,382	-5,224 Reduced 4.65%	107,219 $1.68 Million
Q1 2023 May 12, 2023	BUY	$15.28 - $16.48 $158,316 - $170,749	10,361 Added 10.15%	112,443 $1.85 Million
Q4 2022 Feb 14, 2023	SELL	$12.42 - $15.62 $16,704 - $21,008	-1,345 Reduced 1.3%	102,082 $1.59 Million
Q3 2022 Nov 14, 2022	BUY	$12.8 - $28.65 $172,953 - $387,118	13,512 Added 15.03%	103,427 $1.34 Million
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $712,311 - $816,008	-54,292 Reduced 37.65%	89,915 $1.26 Million
Q1 2022 May 16, 2022	BUY	$13.54 - $15.35 $978,698 - $1.11 Million	72,282 Added 100.5%	144,207 $2.07 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $16.4 $62,373 - $77,670	4,736 Added 7.05%	71,925 $980,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $148,313 - $157,048	9,099 Added 15.66%	67,189 $1.1 Million
Q2 2021 Aug 16, 2021	BUY	$16.55 - $18.64 $276,616 - $311,548	16,714 Added 40.4%	58,090 $978,000
Q1 2021 May 14, 2021	SELL	$16.71 - $19.9 $4,077 - $4,855	-244 Reduced 0.59%	41,376 $755,000
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $575,108 - $708,889	37,369 Added 879.06%	41,620 $757,000
Q3 2020 Dec 16, 2020	SELL	$17.1 - $19.19 $808,060 - $906,823	-47,255 Reduced 91.75%	4,251 $76,000
Q3 2020 Dec 16, 2020	SELL	$17.1 - $19.19 $82,131 - $92,169	-4,803 Reduced 8.53%	51,506 $919,000
Q3 2020 Nov 13, 2020	BUY	$17.1 - $19.19 $117,613 - $131,988	6,878 Added 13.91%	56,309 $1.01 Million
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $330,200 - $441,324	22,632 Added 84.45%	49,431 $886,000
Q1 2020 May 06, 2020	SELL	$13.02 - $20.31 $215,611 - $336,333	-16,560 Reduced 38.19%	26,799 $407,000
Q4 2019 Jan 28, 2020	BUY	$16.88 - $20.83 $147,632 - $182,179	8,746 Added 25.27%	43,359 $855,000
Q3 2019 Oct 31, 2019	BUY	$16.15 - $17.99 $201,358 - $224,299	12,468 Added 56.3%	34,613 $595,000
Q2 2019 Jul 25, 2019	SELL	$16.58 - $20.49 $209,902 - $259,403	-12,660 Reduced 36.37%	22,145 $392,000
Q1 2019 May 09, 2019	BUY	$16.7 - $21.52 $581,243 - $749,003	34,805 New	34,805 $709,000

Others Institutions Holding TAK

# of Institutions

318

Shares Held

70.4M

Call Options Held

939K

Put Options Held

233K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $44.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.

Account

Wetherby Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History